<!DOCTYPE html>
<html lang="es">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Shock Â· Sepsis Â· SDRA Â· VM Â· INGESA 2026</title>
<link href="https://fonts.googleapis.com/css2?family=Playfair+Display:ital,wght@0,700;0,900;1,700&family=Source+Sans+3:wght@300;400;600;700&family=JetBrains+Mono:wght@400;500;600&display=swap" rel="stylesheet">
<style>
:root{
  --bg:#f4f0e8;--surface:#fff;--s2:#faf7f2;--s3:#f0ece3;--border:#e0d5c0;
  --text:#252530;--muted:#7a7080;--gold:#8a6a10;--goldbg:#c8a83a12;
  --shock:#b83030;   /* rojo */
  --sepsis:#8a3aaa;  /* violeta */
  --sdra:#1a5a8a;    /* azul */
  --vm:#2a7a3a;      /* verde */
  --alarm:#b83030;
}
*{margin:0;padding:0;box-sizing:border-box;}
body{font-family:'Source Sans 3',sans-serif;background:var(--bg);color:var(--text);padding:1.5rem 1.2rem 4rem;
  background-image:repeating-linear-gradient(0deg,transparent,transparent 39px,#c8b89810 40px);}
.wrap{max-width:1100px;margin:0 auto;}
header{text-align:center;margin-bottom:2rem;}
.htag{display:inline-flex;align-items:center;gap:.4rem;font-family:'JetBrains Mono',monospace;font-size:.57rem;letter-spacing:.2em;text-transform:uppercase;background:var(--shock);color:#fff;padding:.22rem .9rem;border-radius:2px;margin-bottom:.7rem;}
h1{font-family:'Playfair Display',serif;font-size:clamp(1.7rem,4vw,2.7rem);font-weight:900;line-height:1.05;}
h1 em{color:var(--sepsis);font-style:italic;}
.sdiv{display:flex;align-items:center;gap:.7rem;margin:1.8rem 0 .9rem;}
.sdiv::before,.sdiv::after{content:'';flex:1;height:1px;background:var(--border);}
.sdiv span{font-family:'Playfair Display',serif;font-size:.95rem;white-space:nowrap;padding:.12rem .65rem;border:1px solid var(--border);background:var(--surface);border-radius:2px;}

/* GRID LAYOUTS */
.two-col{display:grid;grid-template-columns:1fr 1fr;gap:.7rem;margin-bottom:.7rem;}
.four-col{display:grid;grid-template-columns:repeat(4,1fr);gap:.55rem;margin-bottom:.7rem;}
@media(max-width:700px){.two-col{grid-template-columns:1fr;}.four-col{grid-template-columns:1fr 1fr;}}
@media(max-width:450px){.four-col{grid-template-columns:1fr;}}

/* TARJETAS SHOCK */
.shock-card{background:var(--surface);border:1px solid var(--border);border-radius:8px;overflow:hidden;}
.shock-head{padding:.5rem .8rem;border-bottom:1px solid var(--border);border-left:5px solid;}
.sh-badge{font-family:'JetBrains Mono',monospace;font-size:.48rem;text-transform:uppercase;letter-spacing:.1em;margin-bottom:.06rem;}
.sh-title{font-family:'Playfair Display',serif;font-size:.95rem;font-weight:700;}
.sh-body{padding:.55rem .8rem;display:flex;flex-direction:column;gap:.2rem;}
.sh-row{font-size:.69rem;color:var(--muted);line-height:1.35;display:flex;gap:.3rem;align-items:flex-start;}
.sh-row::before{content:'â€º';color:var(--gold);font-weight:900;flex-shrink:0;margin-top:.04rem;}
.sh-row strong{color:var(--text);}

/* PARÃMETROS */
.params{display:grid;grid-template-columns:repeat(auto-fit,minmax(120px,1fr));gap:.4rem;margin-bottom:.55rem;}
.p-box{padding:.38rem .55rem;border-radius:5px;border:1px solid;text-align:center;}
.p-lbl{font-family:'JetBrains Mono',monospace;font-size:.47rem;text-transform:uppercase;letter-spacing:.1em;color:var(--muted);margin-bottom:.04rem;}
.p-val{font-family:'Playfair Display',serif;font-size:1.05rem;font-weight:700;line-height:1.1;}
.p-note{font-size:.58rem;color:var(--muted);line-height:1.25;}

/* TABLA */
.etab{width:100%;border-collapse:collapse;font-size:.7rem;margin-bottom:.5rem;}
.etab th{padding:.38rem .6rem;background:var(--s3);border:1px solid var(--border);font-family:'JetBrains Mono',monospace;font-size:.48rem;text-transform:uppercase;letter-spacing:.1em;text-align:left;color:var(--muted);}
.etab td{padding:.38rem .6rem;border:1px solid var(--border);vertical-align:top;line-height:1.35;}
.etab tr:nth-child(even){background:var(--s2);}

/* ESCALAS SEPSIS */
.scale-grid{display:grid;grid-template-columns:repeat(auto-fit,minmax(230px,1fr));gap:.6rem;margin-bottom:.7rem;}
.scale-card{background:var(--surface);border:1px solid var(--border);border-radius:8px;overflow:hidden;}
.sc-head{padding:.5rem .8rem;border-bottom:1px solid var(--border);border-left:5px solid;}
.sc-title{font-family:'Playfair Display',serif;font-size:.9rem;font-weight:700;}
.sc-body{padding:.5rem .8rem;display:flex;flex-direction:column;gap:.2rem;}
.sc-row{font-size:.68rem;color:var(--muted);line-height:1.35;display:flex;gap:.3rem;align-items:flex-start;}
.sc-row::before{content:'â€¢';color:var(--gold);font-weight:900;flex-shrink:0;}
.sc-row strong{color:var(--text);}
.sc-alert{background:#fef0f0;border:1px solid #e09090;border-radius:4px;padding:.28rem .5rem;font-size:.66rem;color:var(--alarm);margin-top:.1rem;line-height:1.35;}

/* BUNDLE HORA-1 */
.bundle{background:var(--surface);border:1px solid var(--border);border-radius:10px;overflow:hidden;margin-bottom:.7rem;}
.bun-head{padding:.6rem .9rem;border-bottom:1px solid var(--border);}
.bun-body{padding:.7rem .9rem;}
.bun-steps{display:flex;flex-direction:column;gap:.3rem;}
.bun-step{display:flex;align-items:stretch;gap:.5rem;}
.bun-num{flex-shrink:0;width:1.6rem;height:1.6rem;display:flex;align-items:center;justify-content:center;border-radius:50%;font-family:'JetBrains Mono',monospace;font-size:.65rem;font-weight:700;}
.bun-content{flex:1;padding:.35rem .65rem;border-radius:5px;border:1px solid;font-size:.7rem;line-height:1.4;}
.bun-content strong{display:block;margin-bottom:.04rem;}

/* SDRA BERLIN */
.berlin{background:var(--surface);border:1px solid var(--border);border-radius:10px;overflow:hidden;margin-bottom:.7rem;}
.ber-head{padding:.6rem .9rem;border-bottom:1px solid var(--border);}
.ber-body{padding:.7rem .9rem;display:grid;grid-template-columns:repeat(3,1fr);gap:.55rem;}
@media(max-width:600px){.ber-body{grid-template-columns:1fr;}}
.ber-col{border-radius:7px;padding:.5rem .7rem;border:1px solid;}
.ber-title{font-family:'Playfair Display',serif;font-size:.9rem;font-weight:700;margin-bottom:.12rem;}
.ber-val{font-family:'JetBrains Mono',monospace;font-size:.75rem;font-weight:700;margin-bottom:.1rem;}
.ber-text{font-size:.67rem;color:var(--muted);line-height:1.35;}
.ber-recoms{margin-top:.1rem;font-size:.63rem;font-style:italic;color:var(--muted);border-top:1px dashed var(--border);padding-top:.1rem;}

/* VM PARÃMETROS */
.vm-wrap{background:var(--surface);border:1px solid var(--border);border-radius:10px;overflow:hidden;margin-bottom:.7rem;}
.vm-head{padding:.6rem .9rem;border-bottom:1px solid var(--border);}
.vm-body{padding:.7rem .9rem;}
.vm-grid{display:grid;grid-template-columns:repeat(auto-fit,minmax(220px,1fr));gap:.5rem;margin-bottom:.5rem;}
.vm-box{background:var(--s2);border:1px solid var(--border);border-radius:6px;padding:.45rem .65rem;}
.vm-lbl{font-family:'JetBrains Mono',monospace;font-size:.5rem;text-transform:uppercase;letter-spacing:.1em;color:var(--muted);margin-bottom:.1rem;}
.vm-val{font-size:.78rem;font-weight:700;color:var(--vm);margin-bottom:.06rem;}
.vm-note{font-size:.65rem;color:var(--muted);line-height:1.3;}

/* PRONO */
.prono-box{background:#e8f0fa;border:2px solid var(--sdra);border-radius:8px;padding:.6rem .85rem;margin-bottom:.6rem;}
.prono-lbl{font-family:'JetBrains Mono',monospace;font-size:.5rem;text-transform:uppercase;letter-spacing:.15em;color:var(--sdra);margin-bottom:.12rem;}
.prono-val{font-family:'Playfair Display',serif;font-size:1.1rem;font-weight:900;color:var(--sdra);margin-bottom:.08rem;}
.prono-text{font-size:.71rem;color:var(--text);font-weight:600;line-height:1.5;}

/* MEMO + TEST */
.memo{background:var(--goldbg);border:1px solid var(--gold);border-radius:5px;padding:.5rem .8rem;margin-bottom:.6rem;}
.memo-l{font-family:'JetBrains Mono',monospace;font-size:.52rem;text-transform:uppercase;letter-spacing:.15em;color:var(--gold);margin-bottom:.1rem;}
.memo-t{font-size:.72rem;color:var(--text);font-weight:600;line-height:1.6;}
.tcard{background:var(--surface);border:1px solid var(--border);border-radius:8px;overflow:hidden;}
.thead{padding:.6rem .9rem;border-bottom:1px solid var(--border);background:#f5eefa;display:flex;align-items:center;gap:.5rem;}
.ttitle{font-family:'Playfair Display',serif;font-size:.95rem;font-weight:700;color:var(--sepsis);}
.tbody{padding:.9rem;}
.qgrid{display:grid;grid-template-columns:repeat(auto-fit,minmax(280px,1fr));gap:0 1.4rem;}
.qb{padding:.42rem 0;border-bottom:1px dashed var(--border);font-size:.72rem;}
.qb:last-child{border-bottom:none;}
.qt{color:var(--muted);margin-bottom:.13rem;line-height:1.35;} .qt::before{content:'â“ ';}
.qa{font-weight:700;color:var(--sepsis);display:flex;align-items:flex-start;gap:.3rem;line-height:1.4;}
.qa::before{content:'â†’';color:var(--gold);font-weight:900;flex-shrink:0;}
</style>
</head>
<body>
<div class="wrap">

<header>
  <div class="htag">ğŸš¨ Urgencias Â· Bloque 2</div>
  <h1>Shock Â· <em>Sepsis</em> Â· SDRA Â· VM</h1>
  <p style="font-family:'JetBrains Mono',monospace;font-size:.57rem;color:var(--muted);text-transform:uppercase;letter-spacing:.18em;margin-top:.45rem;">Surviving Sepsis 2021 Â· BerlÃ­n SDRA Â· ERC Â· SEMICYUC</p>
</header>

<!-- â•â•â• I. TIPOS DE SHOCK â•â•â• -->
<div class="sdiv"><span>ğŸ’¢ I. Tipos de Shock â€” clasificaciÃ³n y manejo â˜…â˜…</span></div>

<div class="four-col">
  <div class="shock-card">
    <div class="shock-head" style="border-left-color:#b83030;background:#fef0f0;">
      <div class="sh-badge" style="color:#b83030;">HipovolÃ©mico</div>
      <div class="sh-title" style="color:#b83030;">Shock por pÃ©rdida de volumen</div>
    </div>
    <div class="sh-body">
      <div class="sh-row"><strong>Causas:</strong> hemorragia, deshidrataciÃ³n, quemaduras, 3.er espacio</div>
      <div class="sh-row"><strong>FisiopatologÃ­a:</strong> â†“ precarga â†’ â†“ GC â†’ hipoperfusiÃ³n</div>
      <div class="sh-row"><strong>ClÃ­nica:</strong> piel frÃ­a, PVC baja, colapso yugular, diuresis &lt;0,5 ml/kg/h â˜…</div>
      <div class="sh-row"><strong>Tratamiento:</strong> restaurar volemia (cristaloides, hemoderivados segÃºn causa)</div>
    </div>
  </div>
  <div class="shock-card">
    <div class="shock-head" style="border-left-color:#1a6faa;background:#e8f2fa;">
      <div class="sh-badge" style="color:#1a6faa;">CardiogÃ©nico</div>
      <div class="sh-title" style="color:#1a6faa;">Fallo de bomba</div>
    </div>
    <div class="sh-body">
      <div class="sh-row"><strong>Causas:</strong> IAM, IC descompensada, arritmias, valvulopatÃ­a</div>
      <div class="sh-row"><strong>FisiopatologÃ­a:</strong> â†“ contractilidad â†’ â†“ GC, â†‘ precarga, edema pulmonar</div>
      <div class="sh-row"><strong>ClÃ­nica:</strong> PVC alta, IY, crepitantes, corazÃ³n agrandado</div>
      <div class="sh-row"><strong>Tratamiento:</strong> inotrÃ³picos, diurÃ©ticos, revascularizaciÃ³n si SCA</div>
    </div>
  </div>
  <div class="shock-card">
    <div class="shock-head" style="border-left-color:var(--sepsis);background:#f5eefa;">
      <div class="sh-badge" style="color:var(--sepsis);">Distributivo</div>
      <div class="sh-title" style="color:var(--sepsis);">VasodilataciÃ³n patolÃ³gica</div>
    </div>
    <div class="sh-body">
      <div class="sh-row"><strong>Causas:</strong> sÃ©ptico (mÃ¡s frecuente), anafilÃ¡ctico, neurÃ³geno</div>
      <div class="sh-row"><strong>FisiopatologÃ­a:</strong> â†“ RVS â†’ maldistribuciÃ³n del flujo â†’ hipoperfusiÃ³n tisular</div>
      <div class="sh-row"><strong>ClÃ­nica sÃ©ptico:</strong> piel caliente y eritematosa, PVC baja, taquicardia â˜…</div>
      <div class="sh-row"><strong>Tratamiento:</strong> vasopresores (noradrenalina 1.Âª lÃ­nea â˜…â˜…), antibiÃ³ticos, volumen</div>
    </div>
  </div>
  <div class="shock-card">
    <div class="shock-head" style="border-left-color:var(--vm);background:#eef7f0;">
      <div class="sh-badge" style="color:var(--vm);">Obstructivo</div>
      <div class="sh-title" style="color:var(--vm);">ObstrucciÃ³n al flujo</div>
    </div>
    <div class="sh-body">
      <div class="sh-row"><strong>Causas:</strong> TEP masivo, neumotÃ³rax a tensiÃ³n, taponamiento cardÃ­aco</div>
      <div class="sh-row"><strong>FisiopatologÃ­a:</strong> obstÃ¡culo mecÃ¡nico â†’ â†“ GC, â†‘ precarga</div>
      <div class="sh-row"><strong>ClÃ­nica TEP:</strong> IY, taquicardia, hipoxemia, ECG S1Q3T3 â˜…</div>
      <div class="sh-row"><strong>Tratamiento:</strong> causa especÃ­fica (ACTP, drenaje, fibrinÃ³lisis)</div>
    </div>
  </div>
</div>

<div style="background:var(--surface);border:1px solid var(--border);border-radius:7px;padding:.55rem .85rem;margin-bottom:.7rem;overflow-x:auto;">
  <div style="font-family:'JetBrains Mono',monospace;font-size:.52rem;text-transform:uppercase;letter-spacing:.12em;color:var(--muted);margin-bottom:.35rem;">ParÃ¡metros hemodinÃ¡micos comparativos â˜…</div>
  <table class="etab">
    <thead><tr><th>Tipo</th><th>GC</th><th>PVC/PCP</th><th>RVS</th><th>Piel</th></tr></thead>
    <tbody>
      <tr><td><strong style="color:#b83030;">HipovolÃ©mico</strong></td><td>â†“â†“</td><td>â†“â†“</td><td>â†‘â†‘</td><td>FrÃ­a, pÃ¡lida, sudorosa</td></tr>
      <tr><td><strong style="color:#1a6faa;">CardiogÃ©nico</strong></td><td>â†“â†“</td><td>â†‘â†‘</td><td>â†‘â†‘</td><td>FrÃ­a, pÃ¡lida, sudorosa</td></tr>
      <tr><td><strong style="color:var(--sepsis);">Distributivo/sÃ©ptico</strong></td><td>â†‘ (fase precoz)</td><td>â†“</td><td>â†“â†“</td><td><strong>Caliente</strong>, eritematosa</td></tr>
      <tr><td><strong style="color:var(--vm);">Obstructivo</strong></td><td>â†“â†“</td><td>â†‘</td><td>â†‘</td><td>FrÃ­a, ingurgitaciÃ³n yugular</td></tr>
    </tbody>
  </table>
</div>

<!-- â•â•â• II. SEPSIS â€” DEFINICIÃ“N Y ESCALAS â•â•â• -->
<div class="sdiv"><span>ğŸ¦  II. Sepsis â€” Sepsis-3, escalas y diagnÃ³stico â˜…â˜…</span></div>

<div style="background:var(--surface);border:1px solid var(--border);border-radius:10px;overflow:hidden;margin-bottom:.7rem;">
  <div style="padding:.6rem .9rem;border-bottom:1px solid var(--border);border-left:6px solid var(--sepsis);background:#f5eefa;">
    <div style="font-family:'Playfair Display',serif;font-size:1.05rem;font-weight:700;color:var(--sepsis);">DefiniciÃ³n Sepsis-3 (2016) vigente â˜…â˜…</div>
  </div>
  <div style="padding:.7rem .9rem;">
    <div class="params">
      <div class="p-box" style="background:#f5eefa;border-color:#c090e0;">
        <div class="p-lbl" style="color:var(--sepsis);">Sepsis â˜…â˜…</div>
        <div class="p-val" style="color:var(--sepsis);font-size:.8rem;">DisfunciÃ³n orgÃ¡nica</div>
        <div class="p-note">amenazante para la vida secundaria a respuesta desregulada del huÃ©sped a la infecciÃ³n Â· SOFA â‰¥2 puntos</div>
      </div>
      <div class="p-box" style="background:#fef0f0;border-color:#e09090;">
        <div class="p-lbl" style="color:var(--alarm);">Shock sÃ©ptico â˜…â˜…</div>
        <div class="p-val" style="color:var(--alarm);font-size:.75rem;">Sepsis + hipotensiÃ³n</div>
        <div class="p-note">PAM &lt;65 mmHg que requiere vasopresores + lactato &gt;2 mmol/L tras resucitaciÃ³n adecuada</div>
      </div>
      <div class="p-box" style="background:#fef8e8;border-color:#d0a840;">
        <div class="p-lbl">Mortalidad hospitalaria</div>
        <div class="p-val" style="color:var(--gold);">&gt;10%</div>
        <div class="p-note">Sepsis: ~10-15% Â· Shock sÃ©ptico: ~40%</div>
      </div>
    </div>
  </div>
</div>

<div class="scale-grid">
  <div class="scale-card">
    <div class="sc-head" style="border-left-color:var(--alarm);background:#fef0f0;">
      <div style="font-family:'JetBrains Mono',monospace;font-size:.5rem;color:var(--alarm);text-transform:uppercase;letter-spacing:.1em;margin-bottom:.04rem;">Escala de alerta</div>
      <div class="sc-title" style="color:var(--alarm);">qSOFA â˜…â˜…</div>
    </div>
    <div class="sc-body">
      <div class="sc-row"><strong>3 variables:</strong> GCS &lt;15 Â· FR â‰¥22 rpm Â· PAS â‰¤100 mmHg</div>
      <div class="sc-row">qSOFA positivo: â‰¥2 puntos â†’ sospecha de sepsis</div>
      <div class="sc-row">RÃ¡pido, a pie de cama, sin analÃ­tica</div>
      <div class="sc-alert"><strong>SSC 2021 â˜…â˜…:</strong> RECOMIENDA EN CONTRA de usar qSOFA como herramienta ÃšNICA de screening â€” baja sensibilidad. Solo qSOFA negativo NO descarta sepsis.</div>
    </div>
  </div>
  <div class="scale-card">
    <div class="sc-head" style="border-left-color:var(--sepsis);background:#f5eefa;">
      <div style="font-family:'JetBrains Mono',monospace;font-size:.5rem;color:var(--sepsis);text-transform:uppercase;letter-spacing:.1em;margin-bottom:.04rem;">DisfunciÃ³n orgÃ¡nica</div>
      <div class="sc-title" style="color:var(--sepsis);">SOFA â˜…â˜…</div>
    </div>
    <div class="sc-body">
      <div class="sc-row">6 sistemas: respiratorio (PaOâ‚‚/FiOâ‚‚), coagulaciÃ³n, hepÃ¡tico, cardiovascular, SNC (GCS), renal (creatinina)</div>
      <div class="sc-row">Cada sistema 0-4 puntos Â· SOFA â‰¥2 = disfunciÃ³n orgÃ¡nica = criterio Sepsis-3</div>
      <div class="sc-row"><strong>Criterio diagnÃ³stico oficial de sepsis</strong> segÃºn Sepsis-3 â˜…â˜…</div>
    </div>
  </div>
  <div class="scale-card">
    <div class="sc-head" style="border-left-color:#7a5500;background:#fef8e8;">
      <div style="font-family:'JetBrains Mono',monospace;font-size:.5rem;color:#7a5500;text-transform:uppercase;letter-spacing:.1em;margin-bottom:.04rem;">Criterios clÃ¡sicos (obsoletos)</div>
      <div class="sc-title" style="color:#7a5500;">SIRS â˜…â˜…</div>
    </div>
    <div class="sc-body">
      <div class="sc-row">Temperatura &gt;38 Â°C o &lt;36 Â°C Â· FC &gt;90 lpm Â· FR &gt;20 rpm o PaCOâ‚‚ &lt;32 Â· Leucos &gt;12.000 o &lt;4.000 o &gt;10% bandas</div>
      <div class="sc-row">SIRS positivo: â‰¥2 criterios + causa infecciosa = antes "sepsis"</div>
      <div class="sc-alert"><strong>SSC 2021 â˜…â˜…:</strong> SIRS NO recomendado como herramienta de screening. Sustituido por Sepsis-3/SOFA. SIRS tambiÃ©n positivo en condiciones no infecciosas.</div>
    </div>
  </div>
  <div class="scale-card">
    <div class="sc-head" style="border-left-color:var(--sdra);background:#e8f0fa;">
      <div style="font-family:'JetBrains Mono',monospace;font-size:.5rem;color:var(--sdra);text-transform:uppercase;letter-spacing:.1em;margin-bottom:.04rem;">Escalas de alerta precoz</div>
      <div class="sc-title" style="color:var(--sdra);">NEWS / MEWS â˜…â˜…</div>
    </div>
    <div class="sc-body">
      <div class="sc-row"><strong>NEWS</strong> (National Early Warning Score): FC, FR, SpOâ‚‚, temperatura, PAS, consciencia + Oâ‚‚ suplementario</div>
      <div class="sc-row"><strong>MEWS</strong> (Modified EWS): similar, mÃ¡s sencillo</div>
      <div class="sc-alert"><strong>SSC 2021 â˜…â˜…:</strong> NEWS y MEWS TAMPOCO recomendados como herramienta Ãºnica. Ninguna escala (SIRS, qSOFA, NEWS, MEWS) es suficiente sola â€” usar juicio clÃ­nico.</div>
    </div>
  </div>
</div>

<!-- â•â•â• III. BUNDLE HORA-1 â•â•â• -->
<div class="sdiv"><span>â±ï¸ III. Bundle Hora-1 Sepsis (SSC 2021) â˜…â˜…</span></div>

<div class="bundle">
  <div class="bun-head" style="border-left:5px solid var(--sepsis);background:#f5eefa;">
    <div style="font-family:'Playfair Display',serif;font-size:1rem;font-weight:700;color:var(--sepsis);">Paquete de medidas de la 1.Âª hora â€” iniciar INMEDIATAMENTE ante sospecha de sepsis o shock sÃ©ptico</div>
    <div style="font-size:.63rem;color:var(--muted);">Surviving Sepsis Campaign 2021 Â· 5 acciones en paralelo, no secuenciales</div>
  </div>
  <div class="bun-body">
    <div class="bun-steps">
      <div class="bun-step">
        <div class="bun-num" style="background:#f5eefa;color:var(--sepsis);">1</div>
        <div class="bun-content" style="background:#f5eefa;border-color:#c090e0;">
          <strong>Medir lactato sÃ©rico â˜…â˜…</strong>
          Si lactato &gt;2 mmol/L (18 mg/dL) â†’ repetir a las 2 h para confirmar aclaramiento. Lactato &gt;4 mmol/L = marcador de gravedad
        </div>
      </div>
      <div class="bun-step">
        <div class="bun-num" style="background:#fef0f0;color:var(--alarm);">2</div>
        <div class="bun-content" style="background:#fef0f0;border-color:#e09090;">
          <strong>Hemocultivos antes de antibiÃ³ticos â˜…â˜…</strong>
          Al menos 2 sets (1 aerobio + 1 anaerobio) de sitios distintos Â· NO retrasar antibiÃ³ticos &gt;45 min para obtenerlos
        </div>
      </div>
      <div class="bun-step">
        <div class="bun-num" style="background:#eef7f0;color:var(--vm);">3</div>
        <div class="bun-content" style="background:#eef7f0;border-color:#90c8a0;">
          <strong>Antibioterapia de amplio espectro â˜…â˜…</strong>
          Iniciar en la 1.Âª hora tras reconocimiento Â· EscalaciÃ³n posterior segÃºn cultivos
        </div>
      </div>
      <div class="bun-step">
        <div class="bun-num" style="background:#e8f0fa;color:var(--sdra);">4</div>
        <div class="bun-content" style="background:#e8f0fa;border-color:#a0c0e0;">
          <strong>Cristaloides IV 30 ml/kg â˜…â˜…</strong>
          En hipotensiÃ³n inducida por sepsis o lactato â‰¥4 mmol/L Â· Completar en primeras 3 h Â· Usar medidas dinÃ¡micas para guiar posterior fluidoterapia
        </div>
      </div>
      <div class="bun-step">
        <div class="bun-num" style="background:#fef8e8;color:var(--gold);">5</div>
        <div class="bun-content" style="background:#fef8e8;border-color:#d0a840;">
          <strong>Vasopresores si hipotensiÃ³n persiste â˜…â˜…</strong>
          PAM objetivo â‰¥65 mmHg Â· <strong>Noradrenalina 1.Âª lÃ­nea</strong> â˜…â˜… Â· Vasopresina 2.Âª lÃ­nea si se necesita escalar
        </div>
      </div>
    </div>
  </div>
</div>

<!-- â•â•â• IV. SDRA â€” BERLÃN 2012 â•â•â• -->
<div class="sdiv"><span>ğŸ« IV. SDRA â€” DefiniciÃ³n de BerlÃ­n 2012 â˜…â˜…</span></div>

<div class="berlin">
  <div class="ber-head" style="border-left:5px solid var(--sdra);background:#e8f0fa;">
    <div style="font-family:'Playfair Display',serif;font-size:1rem;font-weight:700;color:var(--sdra);">SÃ­ndrome de Dificultad Respiratoria Aguda â€” ClasificaciÃ³n de BerlÃ­n</div>
    <div style="font-size:.63rem;color:var(--muted);">Criterios generales: inicio agudo (&lt;7 dÃ­as) Â· bilateral difuso en Rx/TC Â· no explicado completamente por fallo cardÃ­aco Â· FiOâ‚‚ con PEEP â‰¥5 cmHâ‚‚O</div>
  </div>
  <div class="ber-body">
    <div class="ber-col" style="background:#fef8e8;border-color:#d0a840;">
      <div class="ber-title" style="color:var(--gold);">SDRA Leve</div>
      <div class="ber-val" style="color:var(--gold);">PaOâ‚‚/FiOâ‚‚: 201â€“300 mmHg</div>
      <div class="ber-text">Con PEEP o CPAP â‰¥5 cmHâ‚‚O</div>
      <div class="ber-recoms">Sin indicaciÃ³n de prono</div>
    </div>
    <div class="ber-col" style="background:#fef3e8;border-color:#d07030;">
      <div class="ber-title" style="color:#b05020;">SDRA Moderado â˜…â˜…</div>
      <div class="ber-val" style="color:#b05020;">PaOâ‚‚/FiOâ‚‚: 101â€“200 mmHg</div>
      <div class="ber-text">Con PEEP â‰¥5 cmHâ‚‚O Â· mortalidad ~25-40%</div>
      <div class="ber-recoms" style="color:#b05020;"><strong>Considerar decÃºbito prono â‰¥12 h/dÃ­a â˜…â˜…</strong></div>
    </div>
    <div class="ber-col" style="background:#fef0f0;border-color:#e09090;">
      <div class="ber-title" style="color:var(--alarm);">SDRA Grave â˜…â˜…</div>
      <div class="ber-val" style="color:var(--alarm);">PaOâ‚‚/FiOâ‚‚: â‰¤100 mmHg</div>
      <div class="ber-text">Con PEEP â‰¥5 cmHâ‚‚O Â· mortalidad ~40-50%</div>
      <div class="ber-recoms" style="color:var(--alarm);"><strong>RECOMENDAR decÃºbito prono â‰¥12 h/dÃ­a â˜…â˜…</strong></div>
    </div>
  </div>
</div>

<!-- DECÃšBITO PRONO -->
<div class="prono-box">
  <div class="prono-lbl">Surviving Sepsis Campaign 2021 â€” RECOMENDACIÃ“N FUERTE â˜…â˜… literal INGESA</div>
  <div class="prono-val">DecÃºbito prono â‰¥ 12 horas/dÃ­a</div>
  <div class="prono-text">
    En SDRA moderado-grave (PaOâ‚‚/FiOâ‚‚ &lt;150 mmHg) asociado a sepsis Â· Mejora oxigenaciÃ³n al redistribuir la perfusiÃ³n y reducir la atelectasia en zonas dependientes Â· 
    El estudio PROSEVA (2013) demostrÃ³ reducciÃ³n de mortalidad a 28 dÃ­as del 32,8% â†’ 16% en SDRA grave con prono precoz Â·
    <strong>Cuidados de enfermerÃ­a en prono:</strong> prevenciÃ³n de UPP (frente, nariz, rodillas, mamas), ojos ocluidos, tubo aÃ©reo seguro, accesos vasculares accesibles, valorar lesiÃ³n plexo braquial
  </div>
</div>

<!-- â•â•â• V. VENTILACIÃ“N MECÃNICA PROTECTORA â•â•â• -->
<div class="sdiv"><span>âš™ï¸ V. VentilaciÃ³n MecÃ¡nica Protectora en SDRA â˜…â˜…</span></div>

<div class="vm-wrap">
  <div class="vm-head" style="border-left:5px solid var(--vm);background:#eef7f0;">
    <div style="font-family:'Playfair Display',serif;font-size:1rem;font-weight:700;color:var(--vm);">Estrategia ventilatoria protectora â€” objetivo: evitar volutrauma y barotrauma</div>
    <div style="font-size:.63rem;color:var(--muted);">ARDSnet + SSC 2021</div>
  </div>
  <div class="vm-body">
    <div class="vm-grid">
      <div class="vm-box">
        <div class="vm-lbl">Volumen tidal (Vt) â˜…â˜…</div>
        <div class="vm-val">4â€“6 ml/kg peso ideal</div>
        <div class="vm-note">ReducciÃ³n del Vt convencional (12 ml/kg). Peso ideal, no real.</div>
      </div>
      <div class="vm-box">
        <div class="vm-lbl">PresiÃ³n plateau â˜…â˜…</div>
        <div class="vm-val">&lt; 30 cmHâ‚‚O</div>
        <div class="vm-note">LÃ­mite superior de presiÃ³n teleinspiratoria para evitar barotrauma</div>
      </div>
      <div class="vm-box">
        <div class="vm-lbl">PEEP â˜…</div>
        <div class="vm-val">â‰¥ 5 cmHâ‚‚O</div>
        <div class="vm-note">En SDRA moderado-grave: PEEP â‰¥10-15 cmHâ‚‚O titulado para FiOâ‚‚</div>
      </div>
      <div class="vm-box">
        <div class="vm-lbl">Driving pressure â˜…</div>
        <div class="vm-val">&lt; 15 cmHâ‚‚O</div>
        <div class="vm-note">Pplat â€“ PEEP. El mejor predictor de mortalidad en SDRA</div>
      </div>
      <div class="vm-box">
        <div class="vm-lbl">FiOâ‚‚</div>
        <div class="vm-val">MÃ­nima eficaz</div>
        <div class="vm-note">Objetivo SpOâ‚‚ 92-96%. Evitar hiperoxia (toxicidad Oâ‚‚)</div>
      </div>
      <div class="vm-box">
        <div class="vm-lbl">SedaciÃ³n/analgesia</div>
        <div class="vm-val">MÃ­nima necesaria</div>
        <div class="vm-note">Analgesia primero (analgosedaciÃ³n). Valorar despertar diario â˜…</div>
      </div>
    </div>
    <div style="background:#eef7f0;border:1px solid #80c090;border-radius:5px;padding:.4rem .65rem;font-size:.7rem;color:var(--text);line-height:1.5;">
      <strong style="color:var(--vm);">Modos ventilatorios habituales:</strong> VCP (VentilaciÃ³n Controlada por PresiÃ³n) o VCV (por Volumen) Â· La monitorizaciÃ³n de curvas de flujo-volumen y presiÃ³n-volumen es responsabilidad de enfermerÃ­a de UCI Â·
      <strong>Alarmas crÃ­ticas:</strong> apnea, desconexiÃ³n, presiÃ³n pico elevada, FiOâ‚‚ baja â†’ actuaciÃ³n inmediata
    </div>
  </div>
</div>

<!-- MEMO -->
<div class="memo">
  <div class="memo-l">ğŸ§  Perlas INGESA â€” Shock Â· Sepsis Â· SDRA</div>
  <div class="memo-t">
    Shock sÃ©ptico: PAM &lt;65 mmHg + vasopresores + lactato &gt;2 mmol/L â˜…â˜… Â·
    Bundle hora-1: <strong>lactato + hemocultivos + antibiÃ³ticos + 30 ml/kg + noradrenalina</strong> â˜…â˜… Â·
    Noradrenalina = vasopresor de 1.Âª lÃ­nea en shock sÃ©ptico â˜…â˜… Â·
    <strong>qSOFA, SIRS, NEWS, MEWS: ninguno recomendado como herramienta ÃšNICA de screening</strong> â˜…â˜… Â·
    SDRA: <strong>Vt 4-6 ml/kg Â· Pplat &lt;30 cmHâ‚‚O</strong> â˜…â˜… Â·
    SDRA moderado-grave: <strong>decÃºbito prono â‰¥12 h/dÃ­a</strong> â˜…â˜… (SSC 2021 recomendaciÃ³n fuerte) Â·
    BerlÃ­n SDRA: leve 201-300 Â· moderado 101-200 Â· grave â‰¤100 mmHg PaOâ‚‚/FiOâ‚‚ â˜…â˜…
  </div>
</div>

<!-- TEST -->
<div class="sdiv"><span>ğŸ¯ Preguntas tipo test</span></div>
<div class="tcard">
  <div class="thead"><span>ğŸ¯</span><span class="ttitle">Test â€” Shock Â· Sepsis Â· SDRA Â· VM Â· INGESA 2026</span></div>
  <div class="tbody"><div class="qgrid">
    <div class="qb"><div class="qt">Â¿CuÃ¡l es el vasopresor de primera lÃ­nea en el shock sÃ©ptico segÃºn SSC 2021?</div><div class="qa"><strong>Noradrenalina</strong> â€” objetivo PAM â‰¥65 mmHg â˜…â˜…</div></div>
    <div class="qb"><div class="qt">Â¿QuÃ© dice la SSC 2021 sobre el qSOFA como herramienta de screening de sepsis?</div><div class="qa"><strong>Recomienda en contra</strong> de usarlo como herramienta Ãºnica â€” baja sensibilidad â˜…â˜…</div></div>
    <div class="qb"><div class="qt">Â¿CuÃ¡nto tiempo debe mantenerse el decÃºbito prono en SDRA moderado-grave?</div><div class="qa"><strong>â‰¥12 horas/dÃ­a</strong> â€” recomendaciÃ³n fuerte SSC 2021 â˜…â˜…</div></div>
    <div class="qb"><div class="qt">Â¿CuÃ¡l es el volumen tidal recomendado en ventilaciÃ³n protectora del SDRA?</div><div class="qa"><strong>4-6 ml/kg</strong> de peso ideal â˜…â˜…</div></div>
    <div class="qb"><div class="qt">Â¿CuÃ¡les son los criterios de shock sÃ©ptico segÃºn Sepsis-3?</div><div class="qa">Sepsis + <strong>PAM &lt;65 mmHg que requiere vasopresores + lactato &gt;2 mmol/L</strong> tras resucitaciÃ³n â˜…â˜…</div></div>
    <div class="qb"><div class="qt">Â¿En quÃ© rango de PaOâ‚‚/FiOâ‚‚ se clasifica el SDRA grave?</div><div class="qa"><strong>â‰¤100 mmHg</strong> con PEEP â‰¥5 cmHâ‚‚O â€” DefiniciÃ³n de BerlÃ­n â˜…â˜…</div></div>
    <div class="qb"><div class="qt">Â¿CuÃ¡l es la acciÃ³n mÃ¡s urgente del bundle hora-1 antes de iniciar antibiÃ³ticos?</div><div class="qa">Extraer <strong>hemocultivos</strong> (al menos 2 sets) ANTES de iniciar antibiÃ³ticos â˜…â˜…</div></div>
    <div class="qb"><div class="qt">Â¿CuÃ¡ntos ml/kg de cristaloides recomienda la SSC 2021 en la primera hora?</div><div class="qa"><strong>30 ml/kg</strong> IV en hipotensiÃ³n o lactato â‰¥4 mmol/L â˜…â˜…</div></div>
    <div class="qb"><div class="qt">Â¿CuÃ¡l es la presiÃ³n plateau mÃ¡xima en ventilaciÃ³n protectora?</div><div class="qa"><strong>&lt;30 cmHâ‚‚O</strong> para evitar barotrauma â˜…â˜…</div></div>
    <div class="qb"><div class="qt">En shock cardiogÃ©nico, Â¿cÃ³mo estÃ¡ la PVC/PCP y las resistencias?</div><div class="qa">PVC <strong>elevada</strong> + GC <strong>bajo</strong> + RVS <strong>elevadas</strong> (diferencia clave vs shock distributivo) â˜…</div></div>
  </div></div>
</div>

</div>
</body>
</html>
